Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mohammed Bari
Demonstration of the Efficacy and Safety of a Novel Substance P (NK1) Receptor Antagonist in Major Depression
Neuropsychopharmacology
Psychiatry
Mental Health
Pharmacology
Related publications
Chronic Stress Decreases the Number of Parvalbumin-Immunoreactive Interneurons in the Hippocampus: Prevention by Treatment With a Substance P Receptor (NK1) Antagonist
Neuropsychopharmacology
Psychiatry
Mental Health
Pharmacology
The Broad-Spectrum Anti-Emetic Activity of the Novel Non-Peptide Tachykinin NK1 Receptor Antagonist GR203040
British Journal of Pharmacology
Pharmacology
Effects of CP-96,345, a Novel Non-Peptide Antagonist of NK1 Receptor, on the Peristalsis in Isolated Guinea Pig Ileum.
The Japanese Journal of Pharmacology
Substance P-Induced Inflammatory Responses in Guinea-Pig Skin: The Effect of Specific NK1 Receptor Antagonists and the Role of Endogenous Mediators
British Journal of Pharmacology
Pharmacology
Efficacy and Safety of Monotherapy by Pegvisomant, a Growth Hormone Receptor Antagonist, in Japanese Patients With Acromegaly
Endocrine Journal
Endocrinology
Metabolism
Diabetes
The Effects of Substance P on Cultured Fibroblastic Synovial Cells Through the NK1-R
The Journal of the Kyushu Dental Society
Effect of TAK-637, a Tachykinin NK1-Receptor Antagonist, on Lower Urinary Tract Function in Cats.
The Japanese Journal of Pharmacology
Antidepressant-Like Effects of a Novel 5-Ht3 Receptor Antagonist 6z in Acute and Chronic Murine Models of Depression
Acta Pharmacologica Sinica
Medicine
Pharmacology
P-Glycoprotein (ABCB1) Limits the Brain Distribution of YQA-14, a Novel Dopamine D3 Receptor Antagonist
Chemical and Pharmaceutical Bulletin
Medicine
Drug Discovery
Chemistry
